18 January 2021 in Lab on a Chip
Irregular hemodynamics affects the progression of various vascular diseases, such atherosclerosis or aneurysms. Despite the extensive hemodynamics studies on animal models, the inter-species differences between humans and animals hamper the translation of such findings. Recent advances in vascular tissue engineering and the suitability of in vitro models for interim analysis have increased the use of in vitro human vascular tissue models. Although the effect of flow on endothelial cell (EC) pathophysiology and EC-flow interactions have been vastly studied in two-dimensional systems, they cannot be used to understand the effect of other micro- and macro-environmental parameters associated with vessel wall diseases. To generate an ideal in vitro model of the vascular system, essential criteria should be included: 1) the presence of smooth muscle cells or perivascular cells underneath an EC monolayer, 2) an elastic mechanical response of tissue to pulsatile flow pressure, 3) flow conditions that accurately mimic the hemodynamics of diseases, and 4) geometrical features required for pathophysiological flow. In this paper, we review currently available in vitro models that include flow dynamics and discuss studies that have tried to address the criteria mentioned above. Finally, we critically review in vitro fluidic models of atherosclerosis, aneurysm, and thrombosis.
15 December 2022 in Smart Materials and Structures
MIMohammad Ebrahim Imanian
Soft piezoresistive wearable conductors have led to a paradigm shift in the monitoring of human bodily motions. Cellular additively manufactured conductors are promising piezoresistive components as they offer mechanical tunability and provide controllable percolation pathways. In the present study, we engineer high surface-area cellular structures with the triply periodic minimal surface (TPMS)-based architectures to tailor their piezoresistive response for use in wearable devices. A simple and economical fabrication process is proposed, wherein a fused deposition modeling 3D printing technique is utilized to fabricate flexible thermoplastic polyurethane (TPU) cellular structures. Interconnectivity of TPMS designs enables the coating of a continuous graphene layer over the TPU internal surfaces via a facile dip-coating process. The effects of pore shape on piezoresistivity are studied in four different TPMS structures (i.e. Primitive, Diamond, Gyroid, and I-WP). Mechanical properties of sensors are evaluated through experimental procedures and computation methods using finite element analysis of the Mooney–Rivlin hyperelastic model. The piezoresistive performance of sensors exhibits durability under cyclic compression loading. Finally, we conclude that the Primitive structure offers suitable piezoresistive characteristics for sensing of walking, whereas the Diamond structure presents favorable results for respiration monitoring.
9 September 2014 in Chemotherapy Research and Practice
LYLadan Mohammadi Yeganeh
Background. Adding taxanes to anthracycline-based adjuvant chemotherapy has shown significant improvement in node-positive breast cancer patients but the optimal dose schedule has still remained undetermined. Objectives. The feasibility of dose-dense epirubicin in combination with cyclophosphamide (EC) followed by weekly paclitaxel as adjuvant chemotherapy in node-positive breast cancer patients was investigated. Methods. All patients were treated with epirubicin (100 mg/m2) and cyclophosphamide (600 mg/m2) every two weeks for four cycles with daily Pegfilgrastim (G-CSF) that was administered 3–10 days after each cycle of epirubicin and cyclophosphamide infusion which followed by (80 mg/m2) paclitaxel for twelve consecutive weeks. Results. Sixty consecutive patients were analyzed, of whom 57 patients (95%) completed the regimen and no case of toxicity-related death was observed. Grade 3/4 hematologic toxicity was uncommon and the most common grade 3/4 nonhematological adverse event was neuropathy disorders. Conclusions. Dose-dense epirubicin and cyclophosphamide followed by weekly paclitaxel with G-CSF support is a well-tolerated and feasible regimen in node-positive breast cancer patients without serious complications.
9 July 2021 in Advanced NanoBiomed Research
Injectable Biomaterials In article number 2000113, Ali Khademhosseini, Samad Ahadian, and co-workers use biocompatible graphene quantum dots for imaging a physically crosslinked and injectable shear...